Microchannel Technologies Corp (MCTC) financial statements (2021 and earlier)
Company profile
| Business Address |
520 S. GRAND AVENUE LOS ANGELES, CA 90071 |
| State of Incorp. | DE |
| Fiscal Year End | August 31 |
| SIC | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 11/30/2019 TTM | 8/31/2019 | 8/31/2018 | 8/31/2017 | 8/31/2016 | 8/31/2015 | 8/31/2014 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 65 | 152 | 5 | 5 | 5 | 6 | 52 | ||
| Cash and cash equivalents | 65 | 152 | 5 | 5 | 5 | 6 | 52 | ||
| Receivables | 10 | ||||||||
| Inventory, net of allowances, customer advances and progress billings | 18 | 2 | |||||||
| Inventory | 18 | 2 | |||||||
| Total current assets: | 93 | 154 | 5 | 5 | 5 | 6 | 52 | ||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 13 | 13 | |||||||
| Long-term investments and receivables | 40 | 40 | |||||||
| Due from related parties | 40 | 40 | |||||||
| Deposits noncurrent assets | 7 | 7 | |||||||
| Other undisclosed noncurrent assets | 65 | ||||||||
| Total noncurrent assets: | 125 | 60 | |||||||
| TOTAL ASSETS: | 217 | 215 | 5 | 5 | 5 | 6 | 52 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 198 | 99 | 40 | 24 | 16 | 9 | 3 | ||
| Accounts payable | 198 | 93 | 12 | 3 | 1 | 1 | 3 | ||
| Accrued liabilities | 6 | ||||||||
| Interest and dividends payable | 0 | 28 | 21 | 14 | 8 | ||||
| Debt | 36 | 33 | 70 | 70 | 70 | 70 | |||
| Derivative instruments and hedges, liabilities | 16 | ||||||||
| Due to related parties | 1 | 1 | 6 | ||||||
| Other undisclosed current liabilities | 14 | 20 | 23 | ||||||
| Total current liabilities: | 265 | 153 | 140 | 94 | 86 | 79 | 3 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 70 | ||||||||
| Long-term debt, excluding current maturities | 70 | ||||||||
| Liabilities, other than long-term debt | 3 | ||||||||
| Accounts payable and accrued liabilities | 3 | ||||||||
| Total noncurrent liabilities: | 73 | ||||||||
| Total liabilities: | 265 | 153 | 140 | 94 | 86 | 79 | 76 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | (47) | 61 | (135) | (89) | (81) | (73) | (25) | ||
| Common stock | 1 | 1 | 18 | 5 | 5 | 5 | 5 | ||
| Additional paid in capital | 1,464 | 1,185 | 585 | 557 | 557 | 557 | 557 | ||
| Accumulated deficit | (1,513) | (1,128) | (738) | (651) | (643) | (635) | (587) | ||
| Stockholders' equity note, subscriptions receivable | (65) | ✕ | ✕ | ||||||
| Other undisclosed stockholders' equity attributable to parent | 65 | 3 | |||||||
| Total stockholders' equity: | (47) | 61 | (135) | (89) | (81) | (73) | (25) | ||
| TOTAL LIABILITIES AND EQUITY: | 217 | 215 | 5 | 5 | 5 | 6 | 52 | ||
Income statement (P&L) ($ in thousands)
| 11/30/2019 TTM | 8/31/2019 | 8/31/2018 | 8/31/2017 | 8/31/2016 | 8/31/2015 | 8/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 15 | 0 | ||||||
| Other income | 5 | 0 | ✕ | |||||
| Cost of revenue (Other undisclosed Cost of revenue) | (3) | |||||||
| Gross profit: | 12 | 0 | ||||||
| Operating expenses | (909) | (550) | (51) | (1) | (2) | (43) | (42) | |
| Other operating expense, net (Other Expenses) | (2) | |||||||
| Other undisclosed operating income (loss) | (5) | (0) | 2 | |||||
| Operating loss: | (902) | (550) | (51) | (1) | (2) | (43) | (42) | |
| Nonoperating income (expense) | (19) | 160 | (3) | |||||
| Interest and debt expense | 140 | 168 | (36) | (7) | (6) | (5) | (3) | |
| Other undisclosed income from continuing operations before equity method investments, income taxes | 160 | |||||||
| Net loss: | (620) | (222) | (87) | (8) | (8) | (48) | (48) | |
| Other undisclosed net income (loss) attributable to parent | (138) | (168) | 3 | |||||
| Net loss available to common stockholders, diluted: | (758) | (390) | (87) | (8) | (8) | (48) | (45) | |
Comprehensive Income ($ in thousands)
| 11/30/2019 TTM | 8/31/2019 | 8/31/2018 | 8/31/2017 | 8/31/2016 | 8/31/2015 | 8/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (620) | (222) | (87) | (8) | (8) | (48) | (48) | |
| Comprehensive loss, net of tax, attributable to parent: | (620) | (222) | (87) | (8) | (8) | (48) | (48) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.